ABCL Competitors & Alternatives
Compare Abcellera Biologics Inc with similar stocks in the same industry
Biotechnology
ABCL
Main Stock$11.49
Tradestie Score
51
Market Cap
$1.78B
Revenue Growth
-0.8%
Analyst Upside
+56.7%
Top Competitors
216 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PTGX
Protagonist Therapeutics, Inc
|
$130.95
|
$3.98B | 28.1 | 45 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$84.95
|
$3.92B | - | 46 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$127.57
|
$3.91B | - | 49 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$24.60
|
$3.83B | - | 42 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$14.62
|
$3.68B | - | 43 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$93.99
|
$3.67B | - | 38 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$13.68
|
$3.59B | 17.2 | 21 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$18.75
|
$3.58B | 8.6 | 46 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$308.79
|
$3.49B | 127.0 | 49 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$9.23
|
$3.40B | 93.6 | 54 | Compare |
More ABCL Analysis
Data updated: Nov 13, 2026 | Industry: Biotechnology (SIC 2834)
216 stocks in this industry